Skip to content
healthcare.dev

Ticagrelor

NDC 72516-017, Ticagrelor, tablet, from Oryza Pharmaceuticals, Inc..

Product NDC
72516-017
Status
Listed
Labeler
Oryza Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208508
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72516-017 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICAGRELOR60 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
72516-017-067251600170660 TABLET in 1 BOTTLE (72516-017-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/461d810e-5b77-5e53-e063-6294a90a64b0
  • NADAC price for package 72516001706

    GET /v1/drugs/nadac/72516001706

Use it

Look up 72516-017 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72516-017 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72516-017. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.